Abstract
Five patients with chronic adult idiopathic thrombocytopenic purpura (ITP) resistant to standard therapy were treated with pulsed high-dose dexamethasone therapy reported by Andersen (six cycles of dexamethasone, 40mg/day for 4 consecutive days every 28 days). Five female patients were enrolled, median age was 35 years and median platelet count was 18×103/μl at the onset of this treatment. One patient achieved a excellent response with this treatment, but the other four patients were resistant. No serious adverse effects were observed. We conclude that pulsed high-dose dexamethasone therapy had a relatively limited effect in resistant, chronic adult ITP.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
